Evaluation of Asymptomatic Bacteriuria and Urinary Tract Infection in Patients With Primary Sjögren's Syndrome.
Bacteriuria
Sjögren’s syndrome
infection
urinary tract
Journal
Archives of rheumatology
ISSN: 2618-6500
Titre abrégé: Arch Rheumatol
Pays: Turkey
ID NLM: 101639000
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
06
02
2019
accepted:
24
12
2019
entrez:
24
3
2021
pubmed:
25
3
2021
medline:
25
3
2021
Statut:
epublish
Résumé
This study aims to determine the frequency and risk factors of bacteriuria and urinary tract infection (UTI) in patients with primary Sjögren's syndrome (SS) and their differences from healthy individuals and rheumatoid arthritis (RA) patients. The study included 107 female primary SS patients (mean age 50.7±11.6 years; range, 23 to 76 years), 53 healthy female control subjects (mean age 46.8±15.5 years; range 21 to 80 years), and 40 females with RA (mean age 51.7±14.2 years; range, 25 to 79 years). Participants were questioned for UTI risk factors and symptoms. Middle stream urine samples were taken and cultured. All participants were examined with urinary symptom questioning survey of American Urological Association (AUA-7). The urine cultures were positive in 18 primary SS patients (16.8%), eight RA patients (20%), and two healthy controls (3.7%). Escherichia coli, enterococci, Klebsiella, streptococci, and candida were detected in SS patients' cultures. Extended-spectrum beta-lactamase was positive in three cultures. Asymptomatic bacteriuria was not detected in any SS patient. The highest AUA-7 score was determined in SS group (p=0.031). Nineteen SS patients had vaginal dryness symptom and their AUA-7 scores were higher than the rest of the SS group. The risk of UTI development was not different between those who had or did not have vaginal dryness. Urinary tract infections are seen more often in SS patients rather than normal population, which may be caused by SS' urinary system effects. It is difficult to distinguish between asymptomatic bacteriuria and infection because of the underlying urinary symptoms. Clinicians must be careful in patients receiving immunosuppressive therapy due to the high frequency of UTIs.
Identifiants
pubmed: 33758816
doi: 10.46497/ArchRheumatol.2020.7427
pmc: PMC7945699
doi:
Types de publication
Journal Article
Langues
eng
Pagination
592-599Informations de copyright
Copyright © 2020, Turkish League Against Rheumatism.
Déclaration de conflit d'intérêts
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Références
J Rheumatol. 1991 Aug;18(8):1180-4
pubmed: 1941820
Clin Infect Dis. 2005 Mar 1;40(5):643-54
pubmed: 15714408
Trans Ophthalmol Soc U K. 1985;104 ( Pt 4):436-8
pubmed: 2412322
Am J Med. 1965 Aug;39:312-8
pubmed: 14320699
Ann Rheum Dis. 2004 Apr;63(4):431-7
pubmed: 15020339
Ann Rheum Dis. 1992 May;51(5):604-6
pubmed: 1616323
Lupus. 2000;9(8):601-6
pubmed: 11035435
Curr Opin Rheumatol. 2000 Sep;12(5):391-8
pubmed: 10990175
Clin Infect Dis. 1999 Oct;29(4):745-58
pubmed: 10589881
Q J Med. 1985 Jun;55(218):271-87
pubmed: 4023171
Clin Infect Dis. 2007 Aug 1;45(3):273-80
pubmed: 17599303
Clin Microbiol Rev. 1995 Oct;8(4):557-84
pubmed: 8665470
Ann Rheum Dis. 2002 Jun;61(6):554-8
pubmed: 12006334
Med Clin North Am. 2011 Jan;95(1):27-41
pubmed: 21095409
Ann Rheum Dis. 2001 Dec;60(12):1141-4
pubmed: 11709457
J Infect. 1999 Mar;38(2):99-106
pubmed: 10342649
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
Clin Infect Dis. 1992 Nov;15 Suppl 1:S216-27
pubmed: 1477233
Intern Med. 2004 Mar;43(3):248-52
pubmed: 15098610